Scarica l'app Stockscreener
0.6591
1.76%
0.0114
Precedente Chiudi:
$0.6477
Aprire:
$0.66
Volume 24 ore:
72,853
Relative Volume:
0.29
Capitalizzazione di mercato:
$14.15M
Reddito:
$93,700
Utile/perdita netta:
$-16.13M
Rapporto P/E:
-0.2354
EPS:
-2.8
Flusso di cassa netto:
$-6.32M
1 W Prestazione:
-2.36%
1M Prestazione:
+22.06%
6M Prestazione:
+53.31%
1 anno Prestazione:
-21.70%
Intervallo 1D:
$0.64
$0.6755
Intervallo di 1 settimana:
$0.6166
$0.70
Portata 52W:
$0.40
$1.17
Ainos Inc Stock (AIMD) Company Profile
Nome
Ainos Inc
Settore
Industria
Telefono
858-869-2986
Indirizzo
AINOS, INC., SAN DIEGO
Confronta AIMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AIMD
Ainos Inc
|
0.6591 | 14.15M | 93,700 | -16.13M | -6.32M | -2.80 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Ainos Inc Borsa (AIMD) Ultime notizie
Ainos (OTCMKTS:AIMD) Shares Up 0.9% – Time to Buy? - Defense World
AI Nose Achieves 85% Accuracy in Elderly Care Monitoring, Targets $29.8B Market | AIMDW Stock News - Stock Titan
Ainos, Inc. (NASDAQ:AIMD) Short Interest Update - Defense World
Ainos announces data on AI Nose in hygiene monitoring - TipRanks
Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80% - ACCESS Newswire
Revolutionary AI Nose Technology Hits 85% Accuracy, Targets $76.5B SmellTech Market for Eldercare Crisis - Stock Titan
AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street - The Arizona Republic
Ainos showcases AI Nose technology at COMPUTEX 2025 - TipRanks
Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner - PharmiWeb.com
Revolutionary AI Nose Gives Robots Sense of Smell: $76B Market Opportunity Unveiled at COMPUTEX - Stock Titan
Ainos reports interim results in VELDONA trial for FCGS - TipRanks
Revolutionary Cat Dental Treatment Achieves Steroid-Free Remission: Clinical Trial Results Revealed - Stock Titan
Ainos Reports Massive 412% Revenue Surge: AI-Powered Scent Technology Breakthrough Targets $50B Market - Stock Titan
Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors - The Globe and Mail
Ainos (OTCMKTS:AIMD) Shares Down 1.8% – Should You Sell? - Defense World
Ainos, Inc. Reports Significant Revenue Growth in Q1 2025 - TipRanks
Ainos Reports First Quarter 2025 Financial Results - Stock Titan
Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - standard-journal.com
AIMDAinos Inc Latest Stock News & Market Updates - Stock Titan
Revolutionary AI Smell Detection System Enters Semiconductor Manufacturing Through ASE Partnership - Stock Titan
Ainos introduces breath sensing equipment to robots in Japan - Mugglehead Magazine
Revolutionary AI Smell Technology Powers Humanoid Robots in $40B Service Robot Market - Stock Titan
Ainos, Inc: Ugo Robotics Partnership Moving Rapidly with AI Nose Installed - Smartkarma
Ainos (OTCMKTS:AIMD) Stock Price Down 2% – Time to Sell? - Defense World
Ainos partners with ugo to launch smell-sensing robot By Investing.com - Investing.com Canada
Ainos, ugo complete first robotic smell integration in Japan - TipRanks
Ainos and ugo Complete First Robotic Smell Integration in Japan - PharmiWeb.com
Ainos partners with ugo to launch smell-sensing robot - Investing.com Australia
Press Release Distribution & PR Platform - ACCESS Newswire
Revolutionary Breakthrough: AI Robot Now Smells Like HumansSee How This Changes Everything - Stock Titan
Ainos And Ugo Complete First Robotic Smell Integration In Japan - Barchart.com
Ainos secures TFDA approval, IRB clearance to advance VELDONA trials - TipRanks
Major Breakthrough: Ainos Secures Two Key Approvals for $3.3B Market Drug Trials - Stock Titan
Groundbreaking AI Smell Technology Achieves 90% Accuracy, Targets Robotics Revolution - Stock Titan
Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor ManufacturingSmell ID Is Scaling - The Globe and Mail
Short Interest in Ainos, Inc. (NASDAQ:AIMD) Expands By 69.5% - Defense World
Ainos (OTCMKTS:AIMD) Shares Down 1.9% – Time to Sell? - Defense World
Revolutionary AI Nose Technology: How Ainos is Digitizing Smell for Smart Manufacturing - Stock Titan
Ainos, Inc. Reports 2024 Financial Results and Strategic Shift - MSN
Short Interest in Ainos, Inc. (NASDAQ:AIMD) Drops By 49.4% - The AM Reporter
Ainos, ASE team up to boost AI scent digitization - evertiq.com
Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 49.4% in February - Defense World
Major Breakthrough: Ainos AI Nose Technology Lands Massive Deal with Semiconductor Giant ASE - StockTitan
Ainos Inc Azioni (AIMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.56%
1.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):